Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | 13 | 0 | 2 | 0 | €178.90 | €247.61 | 38.406% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €195.90 | - | - |
| Exelixis Inc. | 21 | 0 | 2 | 0 | €23.23 | €26.01 | 11.952% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €23.20 | €28.29 | 21.943% |
| Corcept Therapeutics Inc. | 17 | 0 | 0 | 0 | €31.00 | €36.87 | 18.929% |
| Omnicell Inc. | 3 | 2 | 1 | 0 | €40.80 | €36.81 | -9.784% |
| Neurocrine Bioscience | 45 | 0 | 10 | 0 | €115.00 | €149.74 | 30.205% |
| Cipher Pharmaceuticals | 1 | 0 | 0 | 0 | €11.70 | - | - |
| Community Health Systems Inc. | 5 | 3 | 1 | 0 | €4.94 | €5.28 | 6.921% |
| AnaptysBio Inc | 12 | 1 | 3 | 0 | €33.00 | €48.09 | 45.719% |
| Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | €80.00 | €73.50 | -8.125% |
| ShockWave Medical Inc | 2 | 0 | 1 | 0 | €309.20 | - | - |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 0 | 0 | €0.64 | €4.64 | 630.598% |
| Sangamo Therapeutics Inc. | 11 | 15 | 2 | 0 | €0.76 | €3.64 | 377.350% |
| Lexicon Pharmaceuticals Inc. | 8 | 0 | 3 | 0 | €1.55 | €9.13 | 488.241% |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 1 | 1 | €11.50 | €25.11 | 118.324% |
| Immunogen Inc. | 2 | 0 | 0 | 0 | €28.97 | - | - |
| Insmed Inc. | 47 | 0 | 7 | 0 | €68.50 | €77.59 | 13.271% |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.86 | 1772.365% |
| Tenet Healthcare | 42 | 0 | 2 | 0 | €151.00 | €154.91 | 2.591% |
| Amneal Pharmaceuticals Inc | 1 | 0 | 0 | 0 | €7.85 | €10.00 | 27.389% |
| Savara Inc. | 1 | 0 | 0 | 0 | €3.80 | €5.00 | 31.579% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €55.15 | €55.00 | -0.272% |
| HCA Holdings Inc. | 42 | 0 | 4 | 0 | €357.80 | €356.58 | -0.340% |
| Puma Biotechnology Inc. | 2 | 0 | 2 | 0 | €2.22 | - | - |